title: Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats.
abstract: The effects of interleukin-1 beta (IL-1), an endogenous pyrogen, on both the central and peripheral endocrine, sympathetic, and cardiovascular systems were investigated by injecting it intracisternally (IC) and intravenously (IV). Intracisternal injections of IL-1 caused dose-dependent vasopressor responses, which were accompanied by corresponding increases in the abdominal sympathetic discharge. Blood pressure increased gradually, and attained a peak response at 20 to 30 min. Heart rate also increased dose-dependently. Intracerebroventricular pretreatments with indomethacin abolished both the pressor responses and tachycardia. The IV injections similarly elicited vasopressor responses with gradual onset, which were also accompanied by corresponding increases in the abdominal sympathetic firings. However, IL-1 did not constrict the peripheral vasculature in the perfused hindlimb preparation. Both IC and IV injections of IL-1 increased plasma vasopressin and corticotropin dose-dependently after 30 min. These results indicate that IL-1 of both central and peripheral origin may cause vasopressor responses. These may be partly mediated by the release of vasopressor pituitary hormones. The site of action could be a similar region in the central nervous system.
authors.affiliation: Department of Clinical Laboratory and Medicine, Kyoto Prefectural University of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
authors.forename: M
authors.initials: M
authors.lastname: Nishimura
authors.forename: M
authors.initials: M
authors.lastname: Sakamoto
authors.forename: I
authors.initials: I
authors.lastname: Ikegaki
authors.forename: T
authors.initials: T
authors.lastname: Nakanishi
authors.forename: M
authors.initials: M
authors.lastname: Yoshimura
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005334:Fever / Q000503:physiopathology; D006973:Hypertension / Q000097:blood / Q000503:physiopathology; D007213:Indomethacin / Q000494:pharmacology; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007375:Interleukin-1 / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology*; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors; D014474:Unconsciousness / Q000503:physiopathology
chemical_list: D007375:Interleukin-1; D001127:Arginine Vasopressin; D000324:Adrenocorticotropic Hormone; D007213:Indomethacin